2021
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation
Benning TJ, Shah ND, Inselman JW, Van Houten HK, Ross JS, Wyatt KD. Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation. Clinical Trials 2021, 18: 732-740. PMID: 34269090, PMCID: PMC10119689, DOI: 10.1177/17407745211030683.Peer-Reviewed Original ResearchConceptsPediatric Research Equity ActClinical trialsBest PharmaceuticalsOncology drugsDrug utilizationPediatric indicationsLabel changesPediatric-specific evidenceAdministrative claims databasePediatric Hematology/OncologyQuality of evidenceDrug labelling changesHematology/oncologyDrug utilization ratesNew pediatric indicationsLow methodological rigorClaims databaseComparator groupPediatric utilizationTrial characteristicsBACKGROUND/Pediatric useMonthly utilization ratesDrug safetyStudy designEffects of forced disruption in Medicaid managed care on children with asthma
Piwnica‐Worms K, Staiger B, Ross JS, Rosenthal MS, Ndumele CD. Effects of forced disruption in Medicaid managed care on children with asthma. Health Services Research 2021, 56: 668-676. PMID: 33624290, PMCID: PMC8313960, DOI: 10.1111/1475-6773.13643.Peer-Reviewed Original ResearchConceptsPrimary care providersPersistent asthmaCare plansOutpatient visitsCare utilizationCare administrative claims dataEmergency department utilizationHealth care utilizationAdministrative claims dataIndicators of asthmaProportion of childrenPatients outpatientHealth utilizationAdministrative claimsAsthmaCare providersClaims dataNumber of childrenConsistent associationMedicaidVisitsChildrenOutpatientsPercentage point decreaseEnrollment data
2018
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
Jeffery MM, Hooten WM, Henk HJ, Bellolio MF, Hess EP, Meara E, Ross JS, Shah ND. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study. The BMJ 2018, 362: k2833. PMID: 30068513, PMCID: PMC6066997, DOI: 10.1136/bmj.k2833.Peer-Reviewed Original ResearchConceptsMedicare Advantage beneficiariesAverage daily doseDisabled Medicare beneficiariesAged Medicare beneficiariesRetrospective cohort studyDaily doseOpioid useMedicare beneficiariesLong-term useCohort studyCommercial beneficiariesStudy periodUse prevalenceOpioid use prevalenceHigh rateMedicare Advantage populationTerm useAge 65 yearsOpioid use ratesAdministrative claims dataAverage daily dosesProportion of beneficiariesQuarterly prevalenceMorphine equivalentsOpioid prescriptionsPediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS
Kim J, Ross JS, Kapczynski A. Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS. JAMA 2018, 319: 21-22. PMID: 29117365, DOI: 10.1001/jama.2017.16477.Commentaries, Editorials and Letters
2017
Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection
Jeffery MM, Shah ND, Karaca-Mandic P, Ross JS, Rank MA. Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection. The Journal Of Allergy And Clinical Immunology In Practice 2017, 6: 1568-1577.e4. PMID: 28958746, DOI: 10.1016/j.jaip.2017.07.034.Peer-Reviewed Original ResearchConceptsOmalizumab initiationAsthma controlICS-LABAPatient selectionLow adherenceBetter asthma controlCohort of nonusersSuboptimal patient selectionPoor asthma controlLow adherence ratesPatient-level characteristicsLarge US databaseMedicare Advantage beneficiariesAsthma biologicsExacerbation frequencyOmalizumab useIncident useComparison cohortICS/Medication adherenceAdherence ratesPrevalent usersAdministrative claimsAsthmaUtilization trends
2014
Pediatric screening urinalysis: a difference-in-differences analysis of how a 2007 change in guidelines impacted use
Filice CE, Green JC, Rosenthal MS, Ross JS. Pediatric screening urinalysis: a difference-in-differences analysis of how a 2007 change in guidelines impacted use. BMC Pediatrics 2014, 14: 260. PMID: 25303836, PMCID: PMC4287447, DOI: 10.1186/1471-2431-14-260.Peer-Reviewed Original ResearchConceptsChild visitsAdult visitsNational Ambulatory Medical Care SurveyMale childrenAmbulatory Medical Care SurveyPatient race/ethnicityFemale childrenCommunity health centersHigh-quality careRace/ethnicityPatient ageCare SurveyPatient genderAAP recommendationsPhysician specialtyHealth centersPediatrics recommendationsAmerican AcademyUrinalysisChildren 4VisitsYoung adultsMethodsUsing dataPrivate practiceChildren
2009
Economic Evaluation of a Comprehensive Teenage Pregnancy Prevention Program Pilot Program
Rosenthal MS, Ross JS, Bilodeau R, Richter RS, Palley JE, Bradley EH. Economic Evaluation of a Comprehensive Teenage Pregnancy Prevention Program Pilot Program. American Journal Of Preventive Medicine 2009, 37: s280-s287. PMID: 19896030, PMCID: PMC3020976, DOI: 10.1016/j.amepre.2009.08.014.Peer-Reviewed Original ResearchConceptsTeenage pregnancy prevention programsAge 30 yearsPregnancy prevention programsPrevention programsCommunity-based participatory research approachProgram operating costsTotal societal costsUnintended pregnancySocietal economic benefitsHigh-risk neighborhoodsCost effectivenessParticipatory research approachYoung adultsSocietal costsEconomic benefitsAdolescentsTeenage girlsEconomic evaluationComprehensive programPilot programYearsTotal social costSexual educationNeighborhood-based programsProgram participation